OKYO · OKYO Pharma Ltd
$1.64
+0.00 (+0.00%)
At close · Jul 29
Market Cap
$86.07M
Shares
52.48M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.64
Open$1.61
Day$1.59–1.67
52W$1.34–3.35
Avg vol 30d145K
Short int42K · 0.1% float · 1.0d
Short vol46%
DataMay 2022–Jul 2026
Up next
FQ2-27 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 18.2 · elevated
Equity put/call 0.71
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−12%
below
Price vs 50-day avg
+4%
above
RSI (14)
56
neutral
MACD trend
Positive
52-week position
15%
near low
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+6%
trailing
6-month return
−22%
trailing
YTD return
−21%
this year
Relative strength
−29%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+20% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.08% of float · ▲ +29.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
12 holders — near 3-yr high, broad support
Squeeze score
49
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
80%
annualized · 1-yr
Max drawdown
−58%
past year
ATR
6.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−12%
Bearish
Price vs 50-day avg
+4%
Bullish
RSI (14)
56
Neutral
MACD trend
Positive
Bullish
52-week position
15%
Bearish
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+20% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.08% of float · ▲ +29.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
12 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $1
Now $2 · 15%
52-wk high $3
vs 200-day avg -12%
vs 50-day avg +4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OKYO
this stock
OKYO Pharma Ltd
|
$86.07M | -20.8% | — | — | 0.1% |
|
ONC
BeOne Medicines Ltd.
|
$472.90B | +8.8% | +22179.2% | 962.4 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$124.46B | +8.2% | +46.2% | 29.1 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$72.88B | -9.8% | +20.8% | 17.0 | 3.3% |
|
ARGX
Argenx SE
|
$54.57B | +3.7% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
12
- % held
- 12.2%
- Net QoQ
- +5.7M sh
- Top holder
- Sirenia Capital Managemen…
Held
Float
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OKYO | +19.7% | +5.8% | -21.5% | +9.3% | -20.8% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | +20.7% | +5.8% | -29.0% | +10.1% | -29.4% |